Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1458165

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1458165

Global Digital PCR Market Size, Share, Growth Analysis, By Technology(droplet digital PCR and chip-based digital PCR ), By Product Type, By Application - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Digital PCR Market size was valued at USD 5.95 Billion in 2022 and is poised to grow from USD 6.49 Billion in 2023 to USD 13.07 Billion by 2031, at a CAGR of 9.14% during the forecast period (2024-2031).

The Global Digital PCR (Polymerase Chain Reaction) Market is experiencing rapid growth due to rising demand for precise nucleic acid quantification and analysis. Digital PCR, known for its unmatched accuracy and sensitivity, serves as a vital tool in genetic testing, disease diagnosis, and research endeavors, aiming to provide advanced molecular diagnostic solutions. Key drivers include the escalating prevalence of genetic disorders and infectious diseases, alongside a surge in demand for personalized medicine and genomic research advancements. Nonetheless, challenges such as the high cost of digital PCR instruments and limited end-user awareness hinder market progression. Noteworthy trends involve the integration of digital PCR with next-generation sequencing technologies and the development of multiplex digital PCR assays for simultaneous detection of various targets. Despite obstacles, significant expansion opportunities arise from increased adoption in emerging economies, widening applications in oncology and infectious disease diagnostics, and the introduction of innovative products with enhanced features.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital PCR Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital PCR Market Segmental Analysis

Global Digital PCR Market is segmented on the basis of technology, product type, application, and region. By technology, the market is segmented into droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR). By product type, the market is segmented into instruments, reagents and consumables, and software and services. By application, the market is segmented into clinical diagnostics, research, forensics, and environmental monitoring. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital PCR Market

The significant growth of the market for digital polymerase chain reaction (dPCR) is being propelled by remarkable technological advancements. This evolution from traditional PCR techniques enables direct quantification and clonal amplification of nucleic acids, meeting the rising demand for more precise and efficient diagnostic tools. With a surge in research and development efforts, diverse PCR technologies are emerging, presenting substantial advantages and driving further innovation in the field.

Restraints in the Global Digital PCR Market

The widespread uptake of digital PCR technology might encounter obstacles due to the substantial initial expenses linked with acquiring instruments and reagents. Digital PCR platforms demand specialized equipment and consumables, which could pose a financial challenge for research labs or smaller healthcare institutions. Such high expenditures might restrict the availability of digital PCR technology, especially in resource-constrained environments or for researchers facing budgetary limitations.

Market Trends of the Global Digital PCR Market

The integration of digital PCR and NGS technologies offers a comprehensive approach to genomic analysis, as they complement each other effectively. By combining digital PCR's precise quantification with NGS's sequencing capabilities, researchers can acquire both qualitative and quantitative genomic insights. This integrated approach enables the detection of rare genetic variants, validation of NGS findings, and thorough analysis of intricate genomic changes associated with various diseases.

Product Code: SQMIG35G2206

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Digital PCR Market by Technology

  • Market Overview
  • droplet digital PCR (ddPCR) and chip-based digital PCR (cdPCR)

Global Digital PCR Market by Product Type

  • Market Overview
  • instruments
  • reagents and consumables
  • and software and services

Global Digital PCR Market by Application

  • Market Overview
  • clinical diagnostics
  • research
  • forensics
  • and environmental monitoring Image

Global Digital PCR Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fluidigm Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMA(C)rieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JN Medsys (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RainDance Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Formulatrix, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stilla Technologies (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Analytik Jena AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Douglas Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenMark Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quantabio (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!